Printer Friendly
The Free Library
18,914,692 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

LTT Bio-Pharma, Jikei University to Jointly Develop Innovative DDS for Steroids.


Tokyo, Japan, July 5, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - LTT LTT Lews Therin Telamon (Wheel of Time series)
LTT Long-Term Training
LTT Light Tactical Trailer
LTT Lunar Transit Telescope
LTT Limited Team Training
LTT Live Training Transformation
 Bio-Pharma has issued a report on the progress of its current research on a steroid drug discovery system (DDS (1) (Digital Data Storage) See DAT.

(2) (Data Dictionary System) See QuickBuild and OpenDDS.

(3) (Dataphone Digital S
).

In collaboration with the Jikei University School of Medicine, the company has been striving to develop a DDS for steroid hormones. Using polylactic acid (PLA (Programmable Logic Array) A type of programmable logic chip (PLD) that contained arrays of programmable AND and OR gates. PLAs are no longer used. See PLD.

(language, music) Pla - A high-level music programming language, written in SAIL.
) and polyethyleneglycol (PEG), the partners have developed a sustained-release, stealth-type nanosteroid.

Furthermore, in experiments on mice with rheumatoid arthritis, they have confirmed that the new formulation tends to it can effectively exert its therapeutic effect while reducing side effects.

Details of the research will be presented at the 27th Meeting of the Japanese Society of Inflammation and Regeneration, to be held on July 11.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jul 10, 2006
Words:125
Previous Article:Renesas Technology Expands Global Development and Design Capability.
Next Article:Astellas Pharma, Nippon Boehringer Ingelheim Seek Additional Approval for Micardis.



Related Articles
New Drugs Engineered to Fight Asthma.
"Pharma & Bio Ingredients" from Rodman Publications.(Brief Article)
Advance Nanotech Appoints Tony Goncalves to Board of Directors.
LTT Bio-Pharma Wins Governmental Backing for Its Collaborative Research on Nonsteroidal Antiinflammatory Drug.
I'rom, LTT Bio-Pharma to Jointly Deploy Anti-aging Business.
I'rom, LTT Bio-Pharma to Establish Joint Venture for Anti-aging Business.
LTT Bio-Pharma Announces Results of Research on Porous Hydroxyapatite Particles.
LTT Bio-Pharma and Others to Co-develop Adhesive Preparation in China.
Bio-IT World Reports on Technologies and Strategies That Empower Predictive Biology, and Drug Discovery and Development; September Issue Renews...
Which is which and what is what?(Power Plants and Units ...)

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles